Morgan Stanley (NYSE:MS) Shares Sold by Cacti Asset Management LLC

Cacti Asset Management LLC trimmed its holdings in Morgan Stanley (NYSE:MSFree Report) by 2.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 21,500 shares of the financial services provider’s stock after selling 500 shares during the quarter. Cacti Asset Management LLC’s holdings in Morgan Stanley were worth $2,704,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the stock. Franklin Resources Inc. boosted its holdings in shares of Morgan Stanley by 75.2% in the third quarter. Franklin Resources Inc. now owns 7,850,848 shares of the financial services provider’s stock valued at $881,493,000 after acquiring an additional 3,369,520 shares during the period. Healthcare of Ontario Pension Plan Trust Fund raised its stake in shares of Morgan Stanley by 382.4% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,597,800 shares of the financial services provider’s stock worth $166,555,000 after buying an additional 1,266,600 shares in the last quarter. Fisher Asset Management LLC boosted its stake in shares of Morgan Stanley by 2.7% in the third quarter. Fisher Asset Management LLC now owns 22,404,981 shares of the financial services provider’s stock valued at $2,335,495,000 after buying an additional 590,872 shares in the last quarter. HighTower Advisors LLC grew its stake in shares of Morgan Stanley by 71.2% during the 3rd quarter. HighTower Advisors LLC now owns 1,370,572 shares of the financial services provider’s stock worth $140,077,000 after purchasing an additional 569,789 shares during the period. Finally, Zurich Insurance Group Ltd FI purchased a new position in shares of Morgan Stanley in the 2nd quarter valued at about $43,850,000. 84.19% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, Director Stephen J. Luczo sold 60,000 shares of the business’s stock in a transaction on Thursday, October 17th. The stock was sold at an average price of $119.17, for a total transaction of $7,150,200.00. Following the sale, the director now directly owns 138,363 shares of the company’s stock, valued at $16,488,718.71. The trade was a 30.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.24% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several research analysts have weighed in on MS shares. UBS Group upped their target price on shares of Morgan Stanley from $102.00 to $112.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 8th. The Goldman Sachs Group raised their price objective on Morgan Stanley from $106.00 to $121.00 and gave the company a “neutral” rating in a research note on Thursday, October 17th. HSBC lowered Morgan Stanley from a “buy” rating to a “hold” rating and upped their target price for the company from $128.00 to $131.00 in a report on Tuesday, November 26th. Keefe, Bruyette & Woods lifted their price target on Morgan Stanley from $121.00 to $138.00 and gave the stock a “market perform” rating in a research note on Tuesday, December 3rd. Finally, Jefferies Financial Group lifted their target price on shares of Morgan Stanley from $120.00 to $135.00 and gave the stock a “buy” rating in a research report on Thursday, October 17th. Eleven equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $121.80.

View Our Latest Report on MS

Morgan Stanley Stock Performance

MS traded up $0.79 during trading hours on Thursday, hitting $126.51. 1,202,751 shares of the stock were exchanged, compared to its average volume of 6,964,206. Morgan Stanley has a 12 month low of $83.09 and a 12 month high of $136.24. The stock has a 50-day simple moving average of $127.26 and a 200-day simple moving average of $111.09. The company has a debt-to-equity ratio of 3.14, a current ratio of 0.80 and a quick ratio of 0.80. The stock has a market cap of $203.81 billion, a price-to-earnings ratio of 19.26, a price-to-earnings-growth ratio of 1.18 and a beta of 1.35.

Morgan Stanley (NYSE:MSGet Free Report) last announced its earnings results on Wednesday, October 16th. The financial services provider reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.57 by $0.31. The firm had revenue of $15.38 billion for the quarter, compared to the consensus estimate of $14.27 billion. Morgan Stanley had a return on equity of 12.58% and a net margin of 10.64%. Analysts anticipate that Morgan Stanley will post 7.33 earnings per share for the current year.

Morgan Stanley Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Thursday, October 31st were paid a dividend of $0.925 per share. The ex-dividend date of this dividend was Thursday, October 31st. This represents a $3.70 dividend on an annualized basis and a dividend yield of 2.92%. Morgan Stanley’s dividend payout ratio is presently 56.32%.

About Morgan Stanley

(Free Report)

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.

See Also

Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MSFree Report).

Institutional Ownership by Quarter for Morgan Stanley (NYSE:MS)

Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.